On June 2, 2025, Amphastar Pharmaceuticals, Inc. held its Annual Meeting where stockholders approved several amendments to the company's Charter regarding officer exculpation and the removal of a forum selection provision. Additionally, stockholders elected three directors and ratified the appointment of Ernst & Young LLP as the independent auditor for 2025.